Detalhe da pesquisa
1.
RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease.
Clin Immunol
; 265: 110279, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38878807
2.
RGC-32' dual role in smooth muscle cells and atherogenesis.
Clin Immunol
; 238: 109020, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462050
3.
JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response.
Clin Immunol
; 210: 108297, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698073
4.
Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.
Exp Mol Pathol
; 108: 97-104, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986397
5.
RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis.
J Immunol
; 198(10): 3869-3877, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356385
6.
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.
Exp Mol Pathol
; 105(2): 175-180, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028960
7.
Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?
Exp Mol Pathol
; 102(3): 505-514, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533125
8.
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis.
Exp Mol Pathol
; 102(2): 191-197, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28109694
9.
RGC-32 is expressed in the human atherosclerotic arterial wall: Role in C5b-9-induced cell proliferation and migration.
Exp Mol Pathol
; 101(2): 221-230, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619159
10.
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.
Exp Mol Pathol
; 99(3): 498-505, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407760
11.
Letter by Rus et al Regarding Article, "RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis".
Arterioscler Thromb Vasc Biol
; 38(6): e96, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29793993
12.
COVID, complement, and the brain.
Front Immunol
; 14: 1216457, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533859
13.
Role of RGC-32 in multiple sclerosis and neuroinflammation - few answers and many questions.
Front Immunol
; 13: 979414, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172382
14.
RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive Astrocytosis.
Front Immunol
; 12: 705308, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34394104
15.
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in Oligodendrocytes.
Front Immunol
; 11: 619, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328069
16.
Prediction of Neurocognitive Outcome after Moderate-Severe Traumatic Brain Injury Using Serum Neuron-Specific Enolase and S100 biomarkers.
J Med Life
; 13(3): 306-313, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072201
17.
RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis.
Front Immunol
; 11: 608294, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569054
18.
Modeling fate and transport of hydraulic fracturing fluid in the presence of abandoned wells.
J Contam Hydrol
; 221: 58-68, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679092
19.
Role of C5b-9 and RGC-32 in Cancer.
Front Immunol
; 10: 1054, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31156630
20.
RGC-32 and diseases: the first 20 years.
Immunol Res
; 67(2-3): 267-279, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250246